Zdrowie i gospodarka · 06/11/2013

FDA Releases Draft Guidance for Developing Antimycobacterial Drugs for Pulmonary Tuberculosis Treatment

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop new treatments for pulmonary tuberculosis, a serious form of the disease, and is seeking public comment on the document.